Privette Vinnedge et al. demonstrated that DEK expression is associated with positive hormone receptor status in primary breast cancers and is up-regulated in vitro following exposure to the hormones estrogen, progesterone, and androgen. This evidence concerns the gene DEK and breast cancer.